Evozyne, Inc.

Biotechnology company · Chicago, Illinois, United States

Evozyne, Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $81 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Evozyne at a glance

Typebiotechnology company

HeadquartersChicago, Illinois, United States

Earliest incorporation on record2019

SEC CIK1811288

What does Evozyne do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $81 million sold (2023).

Frequently asked questions about Evozyne

Where is Evozyne headquartered?

Evozyne, Inc. is headquartered in Chicago, Illinois, United States.

What does Evozyne do?

Evozyne, Inc. is a biotechnology company.

When was Evozyne founded?

The earliest incorporation on record for Evozyne, Inc. is in 2019, according to public company registers.

Similar companies

Metame Health Inc.Chicago, Illinois, United States
Synapticure, Inc.Chicago, Illinois, United States
BiomeSense, Inc.Chicago, Illinois, United States
Inomagen Therapeutics, Inc.Chicago, Illinois, United States
Nuago Therapeutics, Inc.Chicago, Illinois, United States
Advanced Cooling Therapy, Inc.Chicago, Illinois, United States
Diagnostic Photonics, Inc.Chicago, Illinois, United States
Microsensor Labs, LLCChicago, Illinois, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences